Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsung-Hui Hu

Showing results (21-30 of 364) with videos related to

Pageof 37
Sort By:
Hepatology International|March 5, 2021
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessationYuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, et al.
Journal of Palliative Medicine|September 7, 2021
Associations between Family Satisfaction with End-of-Life Care and Chart-Derived, Process-Based Quality Indicators in Intensive Care UnitsWen-Chi Chou, Chung-Chi Huang, Tsung-Hui Hu, et al.
Hepatology International|July 24, 2015
Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversionChien-Hung Chen, Sheng-Nan Lu, Chuan-Mo Lee, et al.
Diseases of the Colon and Rectum|July 18, 2008
Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studiesMing-Chao Tsai, Jui-Wei Lin, Shung-Eing Lin, et al.
Journal of Proteomics|March 6, 2012
Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cellsTai-Long Pan, Pei-Wen Wang, Chao-Cheng Huang, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2023
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis BChien-Hung Chen, Cheng-Yuan Peng, Tsung-Hui Hu, et al.
Critical Care (London, England)|August 6, 2021
Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavementSiew Tzuh Tang, Chung-Chi Huang, Tsung-Hui Hu, et al.
Digestive Diseases and Sciences|March 6, 2019
Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute ExacerbationYi-Hsing Chen, Sheng-Nan Lu, Jing-Hung Wang, et al.
Plos One|October 5, 2019
Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatmentTe-Ling Ma, Tsung-Hui Hu, Chao-Hung Hung, et al.
The Kaohsiung Journal of Medical Sciences|December 11, 2012
Liver stiffness measurement in cirrhotic patient -- implications of disease activity and treatment efficacyHuang-Wei Xu, Sheng-Nan Lu, Chao-Hung Hung, et al.
Pageof 37

Showing results (21-30 of 364) with videos related to

Sort By:
Pageof 37
Hepatology International|March 5, 2021
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessationYuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, et al.
Journal of Palliative Medicine|September 7, 2021
Associations between Family Satisfaction with End-of-Life Care and Chart-Derived, Process-Based Quality Indicators in Intensive Care UnitsWen-Chi Chou, Chung-Chi Huang, Tsung-Hui Hu, et al.
Hepatology International|July 24, 2015
Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversionChien-Hung Chen, Sheng-Nan Lu, Chuan-Mo Lee, et al.
Diseases of the Colon and Rectum|July 18, 2008
Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studiesMing-Chao Tsai, Jui-Wei Lin, Shung-Eing Lin, et al.
Journal of Proteomics|March 6, 2012
Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cellsTai-Long Pan, Pei-Wen Wang, Chao-Cheng Huang, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2023
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis BChien-Hung Chen, Cheng-Yuan Peng, Tsung-Hui Hu, et al.
Critical Care (London, England)|August 6, 2021
Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavementSiew Tzuh Tang, Chung-Chi Huang, Tsung-Hui Hu, et al.
Digestive Diseases and Sciences|March 6, 2019
Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute ExacerbationYi-Hsing Chen, Sheng-Nan Lu, Jing-Hung Wang, et al.
Plos One|October 5, 2019
Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatmentTe-Ling Ma, Tsung-Hui Hu, Chao-Hung Hung, et al.
The Kaohsiung Journal of Medical Sciences|December 11, 2012
Liver stiffness measurement in cirrhotic patient -- implications of disease activity and treatment efficacyHuang-Wei Xu, Sheng-Nan Lu, Chao-Hung Hung, et al.
Pageof 37